Andrew Figueiredo

Andrew Figueiredo

Dechert LLP

Contact
View Bio
RSS

Latest Posts › FTC Act

Share:

FTC Issues Policy Statement on Patent Listing

The FTC is focusing its attention on the listing of pharmaceutical patents in the FDA’s Orange Book. Patent listing may be the subject of FTC inquiry even absent infringement litigation enforcing the relevant patents....more

9/19/2023  /  Abbreviated New Drug Application (ANDA) , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , FTC Act , Hatch-Waxman , Orange Book , Patent Infringement , Patents , Sherman Act , The Clayton Act
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide